Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine Monotherapy vs Combination with Prednisone in Acute Urticaria
NCT03545464Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2019
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levocetirizine in acute urticaria (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: 7-Days Urticaria Activity Score. Started Sep 2019; status: completed.
02
Drugs
levocetirizine
03
Conditions
acute urticaria
Beyond the preview
Go deeper on NCT03545464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03545464.